Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ANVS
#3492
Annovis Bio, Inc.
2.6
9
-2.54%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-2.54%
Aylık değişim
-9.12%
6 aylık değişim
+14.47%
Yıllık değişim
+46.20%
Önceki kapanış
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Hacim
28
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ANVS
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
6.95 M
8.16 M
8.22 M
11.01 M
19.49 M
—
Valuation ratios
Enterprise value
44.3 M
97.84 M
78.36 M
202.69 M
87.46 M
159.19 M
Price to earnings ratio
—
-9.25
-4.19
-3.04
-2.18
-6.06
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
-14.68
-6.12
-4.27
-2.81
-6.32
Price to book ratio
—
3.01
3.74
-22.04
6.61
8.36
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.67
-0.31
-0.7
-5.51
-1.77
-1.34
Return on equity %
-0.72
-0.33
-0.89
7.25
-2.64
-1.75
Return on invested capital %
-692.95 K
-3.03 M
—
-278.95 K
-5 291.27
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.04
30.54
4.68
2.39
2.83
22.32
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.2
-2.12
-4.43
-1.79
-1.6
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.99
3.48
0.64
0.87
3.88
Net current asset value per share
—
6.03
4.41
1.13
0.9
3.98
Tangible book value per share
—
5.83
3.47
-0.86
0.76
3.83
Working capital per share
—
5.83
3.47
0.66
0.58
3.17
Book value per share
—
5.83
3.47
-0.86
0.76
3.83
Haberler
Annovis Bio, Ocak ayında uzun vadeli Parkinson ilacı çalışmasını başlatacak
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Annovis Bio yöneticisi Hoffman 193.794 dolar değerinde hisse satın aldı
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Annovis Bio Direktörü Hoffman ANVS hisselerinden 69.900 dolar değerinde satın aldı
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Annovis Bio’nun Faz 3 Alzheimer Çalışması %25 Tamamlandı
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion